Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.

Publication

Citation
Prime ME, Brookfield FA, Courtney SM, Gaines S, Marston RW, Ichihara O, Li M, Vaidya D, Williams H, Pedret-Dunn A, Reed L, Schaertl S, Toledo-Sherman L, Beconi M, Macdonald D, Muñoz-Sanjuan I, Dominguez C, Wityak J.: Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease. ACS Med Chem Lett, Volume 3 (9), 2012
Authors
Beconi M, Brookfield FA, Courtney SM, Dominguez C, Gaines S, Ichihara O, Li M, MacDonald D, Marston RW, Munoz-Sanjuan I, Pedret-Dunn A, Prime ME, Reed L, Schaertl S, Toledo-Sherman L, Vaidya D, Williams H, Wityak J.
Journal
ACS Med Chem Lett
Year
2012
PubMed
24900540
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc